Ultrasonic diagnosis of hepatic metastases in patients with stomach cancer and colon cancer

1987 ◽  
Vol 23 (5) ◽  
pp. 814
Author(s):  
J S Kye ◽  
J H Lim ◽  
Y T Ko ◽  
C Y Ahn
Keyword(s):  
Colon Cancer ◽  
Stomach Cancer ◽  
Hepatic Metastases ◽  
Ultrasonic Diagnosis

scholarly journals Risk of primary gastrointestinal cancers following incident non-metastatic breast cancer: a Danish population-based cohort study

2020 ◽  
Vol 7 (1) ◽  
pp. e000413
Author(s):  
Kasper Adelborg ◽  
Dóra Körmendiné Farkas ◽  
Jens Sundbøll ◽  
Lidia Schapira ◽  
Suzanne Tamang ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Colon Cancer ◽  
Cohort Study ◽  
Metastatic Breast Cancer ◽  
Stomach Cancer ◽  
Metastatic Breast ◽  
Population Based ◽  
Gastrointestinal Cancers ◽  
Increased Risk

ObjectiveWe examined the risk of primary gastrointestinal cancers in women with breast cancer and compared this risk with that of the general population.DesignUsing population-based Danish registries, we conducted a cohort study of women with incident non-metastatic breast cancer (1990–2017). We computed cumulative cancer incidences and standardised incidence ratios (SIRs).ResultsAmong 84 972 patients with breast cancer, we observed 2340 gastrointestinal cancers. After 20 years of follow-up, the cumulative incidence of gastrointestinal cancers was 4%, driven mainly by colon cancers. Only risk of stomach cancer was continually increased beyond 1 year following breast cancer. The SIR for colon cancer was neutral during 2–5 years of follow-up and approximately 1.2-fold increased thereafter. For cancer of the oesophagus, the SIR was increased only during 6–10 years. There was a weak association with pancreas cancer beyond 10 years. Between 1990–2006 and 2007–2017, the 1–10 years SIR estimate decreased and reached unity for upper gastrointestinal cancers (oesophagus, stomach, and small intestine). For lower gastrointestinal cancers (colon, rectum, and anal canal), the SIR estimate was increased only after 2007. No temporal effects were observed for the remaining gastrointestinal cancers. Treatment effects were negligible.ConclusionBreast cancer survivors were at increased risk of oesophagus and stomach cancer, but only before 2007. The risk of colon cancer was increased, but only after 2007.

scholarly journals Colonic metastasis after stomach cancer surgery that mimicked primary colon cancer : Case report

2005 ◽  
Vol 66 (2) ◽  
pp. 86-87
Author(s):  
Keizo Yoneda ◽  
Keiji Suzuki ◽  
Kenji Katumata ◽  
Tatehiko Wada ◽  
Fumiaki Katou ◽  
...  
Keyword(s):  
Colon Cancer ◽  
Case Report ◽  
Stomach Cancer ◽  
Cancer Surgery ◽  
Cancer Case ◽  
Colonic Metastasis ◽  
Primary Colon Cancer ◽  
Primary Colon

scholarly journals Colon cancer stem cell markers CD44 and CD133 in patients with colorectal cancer and synchronous hepatic metastases

2015 ◽  
Vol 46 (4) ◽  
pp. 1582-1588 ◽  
Author(s):  
FEIFENG JING ◽  
HUN JIN KIM ◽  
CHANG HYUN KIM ◽  
YOUNG JIN KIM ◽  
JAE HYUK LEE ◽  
...  
Keyword(s):  
Colorectal Cancer ◽  
Colon Cancer ◽  
Stem Cell ◽  
Cancer Stem Cell ◽  
Hepatic Metastases ◽  
Stem Cell Markers ◽  
Cell Markers ◽  
Cancer Stem Cell Markers ◽  
Colon Cancer Stem Cell

Synchronous Hepatic Metastases from Colon Cancer: Changing Treatment Strategies and Results of Surgical Intervention

2008 ◽  
Vol 16 (2) ◽  
pp. 361-370 ◽  
Author(s):  
Bridget N. Fahy ◽  
Michael D’Angelica ◽  
Ronald P. DeMatteo ◽  
Leslie H. Blumgart ◽  
Martin R. Weiser ◽  
...  
Keyword(s):  
Colon Cancer ◽  
Surgical Intervention ◽  
Treatment Strategies ◽  
Hepatic Metastases

scholarly journals Hepatic Arterial Infusion of Oxaliplatin for a Patient with Hepatic Metastases from Colon Cancer Undergoing Hemodialysis

2007 ◽  
Vol 37 (7) ◽  
pp. 540-543 ◽  
Author(s):  
K. Shitara ◽  
M. Munakata ◽  
O. Muto ◽  
R. Okada ◽  
S. Mitobe ◽  
...  
Keyword(s):  
Colon Cancer ◽  
Hepatic Metastases ◽  
Hepatic Arterial Infusion ◽  
Arterial Infusion

scholarly journals A Case of Metachronous Metastatic Stomach Cancer after an Operation for Descending Colon Cancer

2015 ◽  
Vol 76 (4) ◽  
pp. 832-837 ◽  
Author(s):  
Mikito MORI ◽  
Kiyohiko SHUTO ◽  
Chihiro KOSUGI ◽  
Atsushi HIRANO ◽  
Kuniya TANAKA ◽  
...  
Keyword(s):  
Colon Cancer ◽  
Stomach Cancer ◽  
Descending Colon ◽  
Descending Colon Cancer

Barriers for access to isolated liver metastasis treatment in colon cancer in the United States.

2018 ◽  
Vol 36 (4_suppl) ◽  
pp. 833-833
Author(s):  
Andre Luiz De Souza ◽  
Ritesh Rathore ◽  
Shiva Kumar Reddy Mukkamalla
Keyword(s):  
United States ◽  
Colon Cancer ◽  
Liver Metastasis ◽  
Neoadjuvant Chemotherapy ◽  
Multidisciplinary Treatment ◽  
Hepatic Metastases ◽  
Stage Iv ◽  
The United States ◽  
Quality Healthcare ◽  
Isolated Liver

833 Background: Multidisciplinary treatment of stage IV colon cancer with isolated hepatic metastases implies patient’s access to quality healthcare. Here, we evaluate barriers for access to hepatic metastasectomy in the United States. Methods: The National Cancer Database was queried for stage IV colon cancer patients with isolated liver metastasis diagnosed from 2010-2014. Patient demographics, T and N staging, laterality and surgery were among the variables of interest. Pearson Chi square test was used for statistical analysis Results: A total of 3145 patients were identified for analysis. Moderately differentiated, T3 and N1 tumors were the most frequent tumors to be treated with perioperative and neoadjuvant chemotherapy. Neoadjuvant and perioperative chemotherapy correlated with age (p<0.0001) and year of diagnosis (p=0.0289). Left sided tumors were more likely to receive perioperative and neoadjuvant chemotherapy compared to right sided or transverse tumors (p<0.0001). Conclusions: With various degrees of utilization of perioperative and neoadjuvant chemotherapy based on demographic and clinical variables, there exists a great need to close the gap in access to chemotherapy and surgery for colorectal cancer isolated liver metastases. [Table: see text]

Sign in / Sign up

Export Citation Format

Share Document